(210) | Number of the EPO application | 19765136 |
(220) | Filing date of the EPO application | 2019.03.07 |
(80) | EPO patent specification publication (B) | EPB nr. 48/2023, 2023.11.29 |
(110) | EPO patent number | 3761980 |
(11) | Number of the document | MD 3761980 T2 |
(21) | Number of the application | e 2021 0065 |
(71) | Name(s) of applicant(s), code of the country | PLIANT THERAPEUTICS, INC., US; |
(72) | Name(s) of inventor(s), code of the country | CHA Jacob, US; DONG Chengguo, US; HOM Timothy, US; JIANG Lan, US; LEFTHERIS Katerina, US; LI Hui, US; MORGANS JR. David J., US; MUNOZ Manuel, US; REILLY Maureen, US; ZHENG Yajun, US; BAILEY Christopher, US; FINKELSTEIN Darren, US; |
(73) | Name(s) of owner(s), code of the country | PLIANT THERAPEUTICS, INC., US; |
(54) | Title of the invention | Amino acid compounds and methods of use |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | A61K 31/4375 (2006.01.01); C07D 401/12 (2006.01.01); A61P 43/00 (2006.01.01); C07D 471/04 (2006.01.01); C07D 519/00 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2021.02.28 |
(49) | Date of publication of the translation of the validated European patent specification | 2024.09.30 |
(30) | Priority | 201862639988 P, 2018.03.07, US; 201862690933 P, 2018.06.27, US |
(74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
(86) | International application | PCT/US2019/021243, 2019.03.07 |
(87) | International publication | WO 2019/173653, 2019.09.12 |